Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.
Cardinale, D., Guaitoli, G., Tondi, D., Luciani, R., Henrich, S., Salo-Ahen, O.M., Ferrari, S., Marverti, G., Guerrieri, D., Ligabue, A., Frassineti, C., Pozzi, C., Mangani, S., Fessas, D., Guerrini, R., Ponterini, G., Wade, R.C., Costi, M.P.(2011) Proc Natl Acad Sci U S A 108: E542-E549
- PubMed: 21795601 
- DOI: 10.1073/pnas.1104829108
- Primary Citation of Related Structures:  
3N5E, 3N5G - PubMed Abstract: 
Human thymidylate synthase is a homodimeric enzyme that plays a key role in DNA synthesis and is a target for several clinically important anticancer drugs that bind to its active site. We have designed peptides to specifically target its dimer inter ...